195 related articles for article (PubMed ID: 27617734)
1. Agminated melanocytic nevus status post dabrafenib therapy for metastatic melanoma.
Agulló A; Hinds B; Santesteban R; Mitxelena JM; Yanguas I
Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617734
[TBL] [Abstract][Full Text] [Related]
2. Evolution of melanocytic nevi under vemurafenib, followed by combination therapy with dabrafenib and trametinib for metastatic melanoma.
Giurcaneanu C; Nitipir C; Popa LG; Forsea AM; Popescu I; Bumbacea RS
Acta Dermatovenerol Croat; 2015; 23(2):114-21. PubMed ID: 26228819
[TBL] [Abstract][Full Text] [Related]
3. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
4. Agminated acquired melanocytic nevi of the common and dysplastic type.
Bragg JW; Swindle L; Halpern AC; Marghoob AA
J Am Acad Dermatol; 2005 Jan; 52(1):67-73. PubMed ID: 15627083
[TBL] [Abstract][Full Text] [Related]
5. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade.
Mauzo SH; Tetzlaff MT; Nelson K; Amaria R; Patel S; Aung PP; Nagarajan P; Torres-Cabala CA; Diab A; Prieto VG; Curry JL
Int J Dermatol; 2019 Sep; 58(9):1045-1052. PubMed ID: 29152725
[TBL] [Abstract][Full Text] [Related]
6. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
Urso C
J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
[TBL] [Abstract][Full Text] [Related]
7. Sequential monitoring of pigmented lesions during dabrafenib treatment: a prospective study and a literature overview.
Dika E; Lambertini M; Fanti PA; Piraccini BM; Gurioli C; Ravaioli GM; Chessa MA; Traniello Gradassi A; Melotti B; Sperandi F; Patrizi A
G Ital Dermatol Venereol; 2019 Apr; 154(2):170-176. PubMed ID: 28290623
[TBL] [Abstract][Full Text] [Related]
8. Congenital agminated melanocytic nevus--case report.
Rocha CR; Grazziotin TC; Rey MC; Luzzatto L; Bonamigo RR
An Bras Dermatol; 2013; 88(6 Suppl 1):170-2. PubMed ID: 24346910
[TBL] [Abstract][Full Text] [Related]
9. Eruptive melanocytic nevi induced by interferon for nodal metastatic melanoma: case report and review of the literature.
Salopek TG; Mahmood MN
J Cutan Med Surg; 2013; 17(6):410-3. PubMed ID: 24138978
[TBL] [Abstract][Full Text] [Related]
10. BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib.
McClenahan P; Lin LL; Tan JM; Flewell-Smith R; Schaider H; Jagirdar K; Atkinson V; Lambie D; Prow TW; Sturm RA; Soyer HP
JAMA Dermatol; 2014 Oct; 150(10):1079-82. PubMed ID: 24695877
[TBL] [Abstract][Full Text] [Related]
11. Agminated Halo Nevus: A Novel Presentation.
Hassab-El-Naby HMM; Rageh MA
Am J Dermatopathol; 2023 Jun; 45(6):388-390. PubMed ID: 36939134
[TBL] [Abstract][Full Text] [Related]
12. Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.
Flaherty DC; Hoffner BW; Lau BJ; Hamid O; Faries MB
J Surg Oncol; 2015 Dec; 112(8):844-5. PubMed ID: 26503563
[TBL] [Abstract][Full Text] [Related]
13. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma.
Ramani NS; Curry JL; Kapil J; Rapini RP; Tetzlaff MT; Prieto VG; Torres-Cabala CA
Am J Dermatopathol; 2015 Aug; 37(8):e96-9. PubMed ID: 25839886
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.
Anforth RM; Blumetti TC; Kefford RF; Sharma R; Scolyer RA; Kossard S; Long GV; Fernandez-Peñas P
Br J Dermatol; 2012 Nov; 167(5):1153-60. PubMed ID: 22804352
[TBL] [Abstract][Full Text] [Related]
15. Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report.
Casadevall D; Vidal J; Gallardo F; Zuccarino F; Arumí-Uría M; Dalmases A; Bellosillo B; Montagut C
J Med Case Rep; 2016 Jun; 10(1):158. PubMed ID: 27255157
[TBL] [Abstract][Full Text] [Related]
16. Acquired unilateral melanocytic nevi in otherwise normal skin.
Yu X; Nagai H; Nishigori C; Horikawa T
Dermatology; 2008; 217(1):63-5. PubMed ID: 18401177
[TBL] [Abstract][Full Text] [Related]
17. Dabrafenib-associated necrobiotic granulomatous reaction.
Carlos G; Anforth R; Chou S; Fernandez-Peñas P
Australas J Dermatol; 2014 Nov; 55(4):306-8. PubMed ID: 25399793
[No Abstract] [Full Text] [Related]
18. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
19. Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy.
Chen FW; Tseng D; Reddy S; Daud AI; Swetter SM
JAMA Dermatol; 2014 Nov; 150(11):1209-12. PubMed ID: 25142409
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced eruptive melanocytic nevi.
Vena GA; Fargnoli MC; Cassano N; Argenziano G
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):293-300. PubMed ID: 27759434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
